-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
NIKA PHARMACEUTICALS, INC quarterly and annual Net Cash Provided by (Used in) Operating Activities in USD history and change rate from 31 Dec 2020 to 31 Mar 2025.
- NIKA PHARMACEUTICALS, INC Net Cash Provided by (Used in) Operating Activities for the quarter ending 31 Mar 2025 was $12,945, a 85% increase year-over-year.
- NIKA PHARMACEUTICALS, INC annual Net Cash Provided by (Used in) Operating Activities for 2024 was $139,081, a 115% decline from 2023.
- NIKA PHARMACEUTICALS, INC annual Net Cash Provided by (Used in) Operating Activities for 2023 was $64,833, a 292% decline from 2022.
- NIKA PHARMACEUTICALS, INC annual Net Cash Provided by (Used in) Operating Activities for 2022 was $33,715, a 129% increase from 2021.